Skip to main content

infectious disease "clonorchiasis" Treatment, Symptoms, Diagnosis and Industry Outlook


Pune, India, Nov, 2017 /MRFR Press Release/- Market Research Future has a half cooked research report on the Clonorchiasis market.

Market Highlights

The global clonorchiasis market is expected to grow at a CAGR of 5.4% during the forecast period.

Clonorchiasis is an infectious disease caused by the Chinese liver fluke Clonorchis sinensis. Clonorchiasis is dominant in Asian countries and regions, including South Korea, China, Northern Vietnam, and far-eastern Russia. China has the largest population of infected people. In the acute phase, heavier infections can cause fever, chills, epigastric pain, tender hepatomegaly, mild jaundice, and eosinophilia occur. Chronic cholangitis in heavy infections, which may progress to atrophy of liver parenchyma, portal fibrosis, and cirrhosis. Increasing prevalence of clonorchiasis, changing lifestyle, poor diet, and increasing geriatric population have driven the growth of the market. Moreover, increasing healthcare expenditure has fuelled the growth of the market. On the other hand, high cost of the treatment may slow the market growth..

Market Key Players

The key players for the global clonorchiasis market are Pfizer (U.S), Bayer AG (Germany), Provet (Switzerland), Virbac (India), Cipla (India), Novartis AG (Switzerland), CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (U.S.), Arsanis, Inc. (Austria), Novabiotics (U.K.), GlaxoSmithKline plc. (U.K.), and Teva Pharmaceutical Industries Ltd (Taiwan). 

Market Segmentation
The global clonorchiasis market is segmented on the basis of parasites, therapy, and end users.
On the basis of the parasites, the market is segmented into Clonorchis sinensis, Opisthorchis viverrini, Opisthorchis felineus, and others.
On the basis of the therapy, the market is segmented into diagnosis and treatment. The diagnosis is further segmented into microscopic examination, X-ray, serologic tests, and others. The treatment is sub-segmented into praziquantel, cesol, cisticid, biltricide, and others.
On the basis of end users, the market is segmented into hospital, clinics, and others.

Access Complete Details Here: https://www.marketresearchfuture.com/reports/clonorchiasis-market-4686 


Labels:

Comments

Post a Comment

Popular posts from this blog

Orthopedic Implants Market Technology in Healthcare Encompasses Massive Growth by Market Size

Orthopedic Implants Market AI based Trend Overview on Top Industry Players By Product Type (Spinal Implants, Reconstructive Joint Implants, Orthobiologics and others), Biomaterial (Metallic, Polymer, Ceramic), End-User (Hospitals, Orthopedic Centers and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) – Global Forecast till 2025. Orthopedic Implants Market Size is expected to exhibit significant growth over the forecast period which was valued at approximately USD 6,374.86 Million in 2018 and is projected to register a 4.71% CAGR over the forecast period. The orthopedic implant market has witnessed a tectonic surge over the past few years, mainly due to the rising number of replacement surgeries like hip, knee, shoulder, and other joint or bone, These can be referred as a medical device, which is surgically placed within the body of a patient in order to restore functioning of bone by replacing or reinforcing a damaged structure. Request for a FR...
Post a Comment
Read more

Blood Coagulants Market Developments, Industry Size, Global Share Analysis and Future Trends

  Blood Coagulants Market By Types (Coagulation Factor, others), By Indication (Haemophilia, Surgery, other Bleeding Disorders – Middle East & Africa Forecast till 2023 Market Overview: Blood coagulant aids  in improving the coagulation process of blood in order to stop bleeding and fastening the healing process. According to the report that has been published by Market Research Future (MRFR), the Middle East and Africa blood coagulants market is anticipated to project noteworthy expansion at a robust CAGR of 9.5% during the forecast period of 2017-2023. Intended Audience: Medical Research Laboratories Research and Development (R&D) Companies Market Research and Consulting Service Providers Potential Investors Avail a Free Sample@  https://www.marketresearchfuture.com/sample_request/2743 Market Segmentation: The Middle East and Africa blood coagulants market is segmented on the basis of types, indications, and by country. Based on types, the blood coagulants marke...
Post a Comment
Read more

Surgical Chips Market Therapeutic Assessment and Professional Outlook 2020 to 2027

Global Surgical Chips Market is Poised to Expand Enormously By 2027 Registering A Steady CAGR Throughout the Assessment Period (2017 And 2027). Surgical Chips Market Technological Scope and Global Share Overview These technological advancements are leading to widening the applications of these chips for various tasks that have been directed towards reducing the costs of products. The surgical chips market is growing pervasively mainly due to the burgeoning healthcare sector. Additionally, factors such as the advancements in technology and increasing automation in the healthcare sector are substantiating market growth. Avail Free Sample@  https://www.marketresearchfuture.com/sample_request/1310 However, recent developments in surgical chips such as high integration of advanced artificial intelligence (AI)technology along with the spreading awareness towards the advantages and usages of surgical chips for patient tracking, medical records management, and healthcare qua...
Post a Comment
Read more